PNC FINANCIAL SERVICES GROUP, INC. - IMMUNOVANT INC ownership

IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 144 filers reported holding IMMUNOVANT INC in Q1 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.3%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of IMMUNOVANT INC
ValueSharesWeighting
Q3 2023$11,056
-98.6%
288
-99.4%
0.00%
-100.0%
Q4 2022$809,418
+218.7%
45,6010.0%0.00%
Q3 2022$254,000
+42.7%
45,6010.0%0.00%
Q2 2022$178,000
-29.4%
45,601
-0.3%
0.00%
Q1 2022$252,000
-35.9%
45,732
-0.9%
0.00%
Q4 2021$393,000
+26.4%
46,134
+29.1%
0.00%
Q3 2021$311,00035,7450.00%
Other shareholders
IMMUNOVANT INC shareholders Q1 2023
NameSharesValueWeighting ↓
Alpine Global Management, LLC 4,448,017$17,347,0004.39%
Deep Track Capital, LP 9,455,000$36,875,0002.42%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 233$60,000,0000.63%
Octagon Capital Advisors LP 579,061$2,258,0000.60%
Eventide Asset Management 5,372,512$20,953,0000.45%
WITTENBERG INVESTMENT MANAGEMENT, INC. 174,000$679,0000.29%
Frazier Life Sciences Management, L.P. 585,759$2,284,0000.22%
BCK CAPITAL MANAGEMENT LP 54,293$212,0000.16%
PLATINUM INVESTMENT MANAGEMENT LTD 777,590$3,033,0000.12%
Bridgefront Capital, LLC 15,649$61,0000.07%
View complete list of IMMUNOVANT INC shareholders